vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and GRAHAM CORP (GHM). Click either name above to swap in a different company.
GRAHAM CORP is the larger business by last-quarter revenue ($56.7M vs $44.9M, roughly 1.3× AbCellera Biologics Inc.). GRAHAM CORP runs the higher net margin — 5.0% vs -19.9%, a 25.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 20.5%). GRAHAM CORP produced more free cash flow last quarter ($2.4M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 7.5%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.
ABCL vs GHM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $56.7M |
| Net Profit | $-8.9M | $2.8M |
| Gross Margin | — | 23.8% |
| Operating Margin | -63.7% | 5.5% |
| Net Margin | -19.9% | 5.0% |
| Revenue YoY | 788.4% | 20.5% |
| Net Profit YoY | 73.9% | 79.2% |
| EPS (diluted) | $-0.03 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $56.7M | ||
| Q3 25 | $9.0M | $66.0M | ||
| Q2 25 | $17.1M | $55.5M | ||
| Q1 25 | $4.2M | $59.3M | ||
| Q4 24 | $5.0M | $47.0M | ||
| Q3 24 | $6.5M | $53.6M | ||
| Q2 24 | $7.3M | $50.0M | ||
| Q1 24 | $10.0M | $49.1M |
| Q4 25 | $-8.9M | $2.8M | ||
| Q3 25 | $-57.1M | $3.1M | ||
| Q2 25 | $-34.7M | $4.6M | ||
| Q1 25 | $-45.6M | $4.4M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | $-51.1M | $3.3M | ||
| Q2 24 | $-36.9M | $3.0M | ||
| Q1 24 | $-40.6M | $1.3M |
| Q4 25 | — | 23.8% | ||
| Q3 25 | — | 21.7% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 24.8% | ||
| Q3 24 | — | 23.9% | ||
| Q2 24 | — | 24.8% | ||
| Q1 24 | — | 25.9% |
| Q4 25 | -63.7% | 5.5% | ||
| Q3 25 | -851.8% | 6.5% | ||
| Q2 25 | -290.2% | 8.9% | ||
| Q1 25 | -1479.6% | 9.3% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | -1439.4% | 7.9% | ||
| Q2 24 | -1276.2% | 6.5% | ||
| Q1 24 | -551.5% | 3.1% |
| Q4 25 | -19.9% | 5.0% | ||
| Q3 25 | -637.8% | 4.7% | ||
| Q2 25 | -203.3% | 8.3% | ||
| Q1 25 | -1077.2% | 7.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | -785.4% | 6.1% | ||
| Q2 24 | -504.3% | 5.9% | ||
| Q1 24 | -408.0% | 2.7% |
| Q4 25 | $-0.03 | $0.25 | ||
| Q3 25 | $-0.19 | $0.28 | ||
| Q2 25 | $-0.12 | $0.42 | ||
| Q1 25 | $-0.15 | $0.40 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-0.17 | $0.30 | ||
| Q2 24 | $-0.13 | $0.27 | ||
| Q1 24 | $-0.14 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $22.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $131.3M |
| Total Assets | $1.4B | $292.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $22.3M | ||
| Q3 25 | $83.2M | $20.6M | ||
| Q2 25 | $92.4M | $10.8M | ||
| Q1 25 | $159.3M | $21.6M | ||
| Q4 24 | $156.3M | $30.0M | ||
| Q3 24 | $126.6M | $32.3M | ||
| Q2 24 | $148.3M | $21.6M | ||
| Q1 24 | $123.6M | $16.9M |
| Q4 25 | $966.9M | $131.3M | ||
| Q3 25 | $964.0M | $127.6M | ||
| Q2 25 | $1.0B | $123.4M | ||
| Q1 25 | $1.0B | $119.6M | ||
| Q4 24 | $1.1B | $114.4M | ||
| Q3 24 | $1.1B | $112.5M | ||
| Q2 24 | $1.1B | $108.2M | ||
| Q1 24 | $1.1B | $105.6M |
| Q4 25 | $1.4B | $292.9M | ||
| Q3 25 | $1.4B | $287.0M | ||
| Q2 25 | $1.4B | $252.3M | ||
| Q1 25 | $1.3B | $264.1M | ||
| Q4 24 | $1.4B | $264.3M | ||
| Q3 24 | $1.4B | $249.5M | ||
| Q2 24 | $1.4B | $244.2M | ||
| Q1 24 | $1.5B | $233.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $4.8M |
| Free Cash FlowOCF − Capex | $-44.6M | $2.4M |
| FCF MarginFCF / Revenue | -99.4% | 4.3% |
| Capex IntensityCapex / Revenue | 21.9% | 4.1% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-6.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $4.8M | ||
| Q3 25 | $-52.6M | $13.6M | ||
| Q2 25 | $-32.4M | $-2.3M | ||
| Q1 25 | $-11.6M | $-3.6M | ||
| Q4 24 | $-108.6M | $5.2M | ||
| Q3 24 | $-28.9M | $13.9M | ||
| Q2 24 | $-30.0M | $8.7M | ||
| Q1 24 | $-41.7M | $8.6M |
| Q4 25 | $-44.6M | $2.4M | ||
| Q3 25 | $-61.5M | $9.4M | ||
| Q2 25 | $-45.8M | $-9.3M | ||
| Q1 25 | $-22.2M | $-8.7M | ||
| Q4 24 | $-187.0M | $-2.1M | ||
| Q3 24 | $-47.4M | $10.4M | ||
| Q2 24 | $-50.1M | $5.7M | ||
| Q1 24 | $-65.8M | $4.6M |
| Q4 25 | -99.4% | 4.3% | ||
| Q3 25 | -687.0% | 14.3% | ||
| Q2 25 | -267.9% | -16.7% | ||
| Q1 25 | -524.0% | -14.7% | ||
| Q4 24 | -3702.8% | -4.5% | ||
| Q3 24 | -728.4% | 19.5% | ||
| Q2 24 | -683.8% | 11.5% | ||
| Q1 24 | -661.5% | 9.4% |
| Q4 25 | 21.9% | 4.1% | ||
| Q3 25 | 99.7% | 6.3% | ||
| Q2 25 | 78.2% | 12.6% | ||
| Q1 25 | 251.1% | 8.7% | ||
| Q4 24 | 1552.7% | 15.6% | ||
| Q3 24 | 284.6% | 6.5% | ||
| Q2 24 | 274.6% | 6.0% | ||
| Q1 24 | 242.5% | 8.2% |
| Q4 25 | — | 1.67× | ||
| Q3 25 | — | 4.40× | ||
| Q2 25 | — | -0.49× | ||
| Q1 25 | — | -0.81× | ||
| Q4 24 | — | 3.29× | ||
| Q3 24 | — | 4.25× | ||
| Q2 24 | — | 2.94× | ||
| Q1 24 | — | 6.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
GHM
| Defense | $35.3M | 62% |
| Energy And Process | $18.3M | 32% |
| Space | $3.1M | 6% |
